Rhythm Biosciences Ltd has released a press release.
EGM - Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
In the deck
Story so far
Earlier from Rhythm Biosciences
- RHY Genetype Commercial Sales
- RHY Investor Webinar
- Genetype Commercial Integration Completion
- Quarterly Activities Report and Appendix 4C - Dec24
- About the Genetype Acquisition
Later from Rhythm Biosciences
- Quarterly Activities Report and Appendix 4C 31 March 2025
- Breast Cancer Risk Study University of Melbourne
- ColoSTAT Beta kit verification and validation update
- NATA Accreditation Awarded for Genetype Laboratory
- FY2025 R&D Tax Incentive Loan Funding
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences